Cargando…
A Randomized, Controlled, Prospective Study of the Effectiveness and Safety of an Intracanalicular Dexamethasone Ophthalmic Insert (0.4 Mg) for the Treatment of Post-Operative Inflammation in Patients Undergoing Refractive Lens Exchange (RLE)
PURPOSE: To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4 mg) insert compared to standard steroid drop regimen in the contralateral eye following bilateral RLE surgery. METHODS: This is a prospective, open-label, interventional, randomized, controlle...
Autores principales: | Larsen, Jacob, Whitt, Travis, Parker, Briana, Swan, Russell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166314/ https://www.ncbi.nlm.nih.gov/pubmed/34079218 http://dx.doi.org/10.2147/OPTH.S311070 |
Ejemplares similares
-
Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
por: Brooks, Cassandra C, et al.
Publicado: (2020) -
Prospective, Randomized, Fellow Eye-Controlled Study of Postoperative Pain and Inflammation Control with an Intracanalicular Dexamethasone 0.4 mg Ophthalmic Insert Following Small Incision Lenticule Extraction
por: Jee, Kathleen J, et al.
Publicado: (2022) -
Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative survey
por: Gira, Joseph P, et al.
Publicado: (2017) -
Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert
por: Matossian, Cynthia, et al.
Publicado: (2022) -
In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study
por: Ibach, Mitchel J, et al.
Publicado: (2022)